Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy

被引：1
|
作者：
Wang, Chrong-Reen [4 ]
Tsai, Hung-Wen [1 ]
Wu, I-Chin [2 ,3 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Rheumatol & Immunol, Tainan, Taiwan
[2] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan, Taiwan
[3] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Tainan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Internal Med, 138 Sheng Li Rd, Tainan 70403, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2023年 / 122卷 / 12期
关键词：
D O I：
10.1016/j.jfma.2023.05.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1345 / 1346
页数：2
相关论文
共 50 条
  • [1] A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Haruki Koike
    Ryoji Nishi
    Satoru Yagi
    Soma Furukawa
    Yuki Fukami
    Masahiro Iijima
    Masahisa Katsuno
    Advances in Therapy, 2023, 40 : 25 - 40
  • [2] A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Koike, Haruki
    Nishi, Ryoji
    Yagi, Satoru
    Furukawa, Soma
    Fukami, Yuki
    Iijima, Masahiro
    Katsuno, Masahisa
    ADVANCES IN THERAPY, 2023, 40 (01) : 25 - 40
  • [3] Correction to: A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis
    Haruki Koike
    Ryoji Nishi
    Satoru Yagi
    Soma Furukawa
    Yuki Fukami
    Masahiro Iijima
    Masahisa Katsuno
    Advances in Therapy, 2023, 40 : 718 - 718
  • [4] The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis
    Nagase, Hiroyuki
    Ueki, Shigeharu
    Fujieda, Shigeharu
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (02) : 178 - 186
  • [5] Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis
    Bizymi, N.
    Matthaiou, A. M.
    Stathakis, G.
    Viziriannaki, S.
    Bibaki, E.
    Tzanakis, N.
    Antoniou, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [6] ANTI-IGE AND ANTI-IL5 THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Solans-Laque, Roser
    Fonseca, Eva
    Luis Callejas-Rubio, Jose
    Martinez-Zapico, Aleida
    Solanich, Xavier
    Miguel Lopez-Dupla, Jesu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 812 - 813
  • [7] Anti-IL5 /Rituximab Therapy for Patients suffering from therapy-refractory Eosinophilic Granulomatosis with Polyangiitis
    Gysan, Maximilian Robert
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 601 - 601
  • [8] Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis
    Stein, Miguel L.
    Collins, Margaret H.
    Villanueva, Joyce M.
    Kushner, Jonathan P.
    Putnam, Philip E.
    Buckmeier, Bridget K.
    Filipovich, Alexandra H.
    Assa'ad, Amal H.
    Rothenberg, Marc E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (06) : 1312 - 1319
  • [9] Rituximab For Refractory Granulomatosis With Polyangiitis And For Eosinophilic Granulomatosis With Polyangiitis
    Kawano-Dourado, L.
    De Oliveira Filho, J. B.
    Lima, R. M.
    Tavares, M. S.
    Barbas, C. S. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [10] Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study
    Akdime, F.
    Habib, S.
    Regard, L.
    Terrier, B.
    Cohen, P.
    Mouthon, L.
    Guillevin, L.
    Burgel, P. R.
    Honore, I.
    Puechal, X.
    Roche, N.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (9-10) : 732 - 742
12345